NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

26.67

-1.16 (-4.17%)

At close: Aug 13, 2026, 4:00 PM EDT

27.20

+0.53 (1.99%)

After-hours: Aug 13, 2026, 7:34 PM EDT

NAMS Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	7.12	22.5	45.56	14.09	102.69	-
Revenue Growth	-88.87%	-50.61%	223.37%	-86.28%	-	-
Gross Profit	7.12	22.5	45.56	14.09	102.69	-
Selling, General & Admin	-115.06	-110.99	-73.22	37.63	-22.91	-5.46
Research & Development	-131.47	-138.89	-152.78	159.42	-88.46	-28.47
Other Operating Expenses	-	-	-	-	62.26	-
Total Operating Expenses	-246.54	-249.88	-226	197.06	-49.11	-33.93
Operating Income	-246.1	-227.37	-180.44	-182.97	-70.94	-33.93
Interest Income	24.65	27.59	16.88	11.28	0.01	0.01
Interest Expense	-	-0.02	-0.03	-	-0.29	-0.25
Other Non-Operating Income (Expense)	-0.62	-5.73	-82.19	-5.23	-10.79	1.64
Total Non-Operating Income (Expense)	24.03	21.84	-65.34	6.06	-11.06	1.41
Pretax Income	-261.22	-205.53	-245.78	-176.91	-82	-32.52
Provision for Income Taxes	-	-	0	0.03	-	-
Net Income	-261.22	-205.53	-245.78	-176.94	-82	-32.52
Net Income to Common	-261.22	-205.53	-245.78	-176.94	-82	-32.52
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	121	118	94	82	19	24
Shares Outstanding (Diluted)	121	118	94	82	19	24
Shares Change	12.87%	25.50%	14.84%	333.20%	-19.76%	156.56%
EPS (Basic)	-2.18	-1.74	-2.60	-2.15	-1.19	-1.38
EPS (Diluted)	-2.18	-1.74	-2.60	-2.15	-1.19	-1.38
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-138.95	-143.26	-159.05	-141.24	7.02	-28.64
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-1.15	-1.21	-1.69	-1.72	0.37	-1.21
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	-
Operating Margin	-3455.95%	-1010.42%	-396.02%	-1298.56%	-69.08%	-
Profit Margin	-3668.29%	-913.36%	-539.42%	-1255.76%	-79.85%	-
FCF Margin	-1951.33%	-636.63%	-349.08%	-1002.43%	6.83%	-
EBITDA	-245.74	-227.04	-180.21	-182.92	-70.86	-33.91
EBITDA Margin	-3450.88%	-1008.92%	-395.51%	-1298.21%	-69.00%	-
EBIT	-246.1	-227.37	-180.44	-182.97	-70.94	-33.93
EBIT Margin	-3455.95%	-1010.42%	-396.02%	-1298.56%	-69.08%	-
Effective Tax Rate	-	0.00%	-0.00%	-0.02%	0.00%	0.00%

SEC Filings: 10-K · 10-Q